|Last Price$24.82||Day Change (%)-0.20%|
|Open Price$24.82||Day Change ($)-0.05|
|Day Range24.82–24.82||52-Week Range20.03–25.01|
As of Fri 04/28/2017 | USD
Dr. Reddy's Laboratories Announces the Launch of Ezetimibe and Simvastatin Tablets in the U.S. Market
UPDATE: Amgen likely aiming to meet, not beat, first-quarter earnings expectations
Pricey rare disease drug's launch will be likely focus of Biogen earnings
Amgen likely aiming to meet, not beat, first-quarter earnings expectations
Dr. Reddy's Laboratories Announces the Launch of Progesterone Capsules in the U.S. Market
Despite the Fed taper, a U.S. economy struggling to shake off the winter blues, and a slowing China, stocks continued their remarkable winning streak from April through June.
IMS Health is on the right track for growth.
A look back at the winners and losers of the final quarter of a tumultuous year.